50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Endometrial Decidualization: The Primary Driver of Pregnancy Health

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Interventions to prevent pregnancy complications have been largely unsuccessful. We suggest this is because the foundation for a healthy pregnancy is laid prior to the establishment of the pregnancy at the time of endometrial decidualization. Humans are one of only a few mammalian viviparous species in which decidualization begins during the latter half of each menstrual cycle and is therefore independent of the conceptus. Failure to adequately prepare (decidualize) the endometrium hormonally, biochemically, and immunologically in anticipation of the approaching blastocyst—including the downregulation of genes involved in the pro- inflammatory response and resisting tissue invasion along with the increased expression of genes that promote angiogenesis, foster immune tolerance, and facilitate tissue invasion—leads to abnormal implantation/placentation and ultimately to adverse pregnancy outcome. We hypothesize, therefore, that the primary driver of pregnancy health is the quality of the soil, not the seed.

          Related collections

          Most cited references122

          • Record: found
          • Abstract: found
          • Article: not found

          Cyclic decidualization of the human endometrium in reproductive health and failure.

          Decidualization denotes the transformation of endometrial stromal fibroblasts into specialized secretory decidual cells that provide a nutritive and immunoprivileged matrix essential for embryo implantation and placental development. In contrast to most mammals, decidualization of the human endometrium does not require embryo implantation. Instead, this process is driven by the postovulatory rise in progesterone levels and increasing local cAMP production. In response to falling progesterone levels, spontaneous decidualization causes menstrual shedding and cyclic regeneration of the endometrium. A growing body of evidence indicates that the shift from embryonic to maternal control of the decidual process represents a pivotal evolutionary adaptation to the challenge posed by invasive and chromosomally diverse human embryos. This concept is predicated on the ability of decidualizing stromal cells to respond to individual embryos in a manner that either promotes implantation and further development or facilitates early rejection. Furthermore, menstruation and cyclic regeneration involves stem cell recruitment and renders the endometrium intrinsically capable of adapting its decidual response to maximize reproductive success. Here we review the endocrine, paracrine, and autocrine cues that tightly govern this differentiation process. In response to activation of various signaling pathways and genome-wide chromatin remodeling, evolutionarily conserved transcriptional factors gain access to the decidua-specific regulatory circuitry. Once initiated, the decidual process is poised to transit through distinct phenotypic phases that underpin endometrial receptivity, embryo selection, and, ultimately, resolution of pregnancy. We discuss how disorders that subvert the programming, initiation, or progression of decidualization compromise reproductive health and predispose for pregnancy failure.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Molecular cues to implantation.

            Successful implantation is the result of reciprocal interactions between the implantation-competent blastocyst and receptive uterus. Although various cellular aspects and molecular pathways of this dialogue have been identified, a comprehensive understanding of the implantation process is still missing. The receptive state of the uterus, which lasts for a limited period, is defined as the time when the uterine environment is conducive to blastocyst acceptance and implantation. A better understanding of the molecular signals that regulate uterine receptivity and implantation competency of the blastocyst is of clinical relevance because unraveling the nature of these signals may lead to strategies to correct implantation failure and improve pregnancy rates. Gene expression studies and genetically engineered mouse models have provided valuable clues to the implantation process with respect to specific growth factors, cytokines, lipid mediators, adhesion molecules, and transcription factors. However, a staggering amount of information from microarray experiments is also being generated at a rapid pace. If properly annotated and explored, this information will expand our knowledge regarding yet-to-be-identified unique, complementary, and/or redundant molecular pathways in implantation. It is hoped that the forthcoming information will generate new ideas and concepts for a process that is essential for maintaining procreation and solving major reproductive health issues in women.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Immunology of pre-eclampsia.

              Pre-eclampsia develops in stages, only the last being the clinical illness. This is generated by a non-specific, systemic (vascular), inflammatory response, secondary to placental oxidative stress and not by reactivity to fetal alloantigens. However, maternal adaptation to fetal (paternal alloantigens) is crucial in the earlier stages. A pre-conceptual phase involves maternal tolerization to paternal antigens by seminal plasma. After conception, regulatory T cells, interacting with indoleamine 2,3-dioxygenase, together with decidual NK cell recognition of fetal HLA-C on extravillous trophoblast may facilitate placental growth by immunoregulation. Complete failure of this mechanism would cause miscarriage, while partial failure would cause poor placentation and dysfunctional uteroplacental perfusion. The first pregnancy preponderance and partner specificity of pre-eclampsia can be explained by this model. For the first time, the pathogenesis of pre-eclampsia can be related to defined immune mechanisms that are appropriate to the fetomaternal frontier. Now, the challenge is to prove the detail.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                08 June 2020
                June 2020
                : 21
                : 11
                : 4092
                Affiliations
                [1 ]Department of Obstetrics & Gynecology, Tufts University School of Medicine, Boston, MA 02111, USA
                [2 ]Mother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA
                [3 ]School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA; gnorwitz@ 123456umich.edu
                [4 ]Department of Theoretical Biology, University of Vienna, 1010 Vienna, Austria; mihaela.pavlicev@ 123456univie.ac.at
                [5 ]Division of Immunobiology and Center for Inflammation and Tolerance, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA; tamara.tilburgs@ 123456cchmc.org
                [6 ]Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA
                [7 ]Department of Obstetrics & Gynecology, Valencia University and INCLIVA, 46010 Valencia, Spain; carlos.simon@ 123456uv.es
                [8 ]Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 02215, USA
                [9 ]Igenomix Foundation and INCLIVA, 46010 Valencia, Spain
                Author notes
                [* ]Correspondence: sng1@ 123456tuftsmedicalcenter.org (S.-W.N.); enorwitz@ 123456tuftsmedicalcenter.org (E.R.N.); Tel.: +617-636-8950 (S.-W.N.); +617-636-2382 (E.R.N.)
                Author information
                https://orcid.org/0000-0001-8439-9351
                Article
                ijms-21-04092
                10.3390/ijms21114092
                7312091
                32521725
                e10414b8-06a4-4687-8836-3614f34fa6d1
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 24 April 2020
                : 05 June 2020
                Categories
                Review

                Molecular biology
                endometrium,decidualization,adverse pregnancy outcome,preconception
                Molecular biology
                endometrium, decidualization, adverse pregnancy outcome, preconception

                Comments

                Comment on this article